[Corrigendum] Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells

Chiu,Yu-Jen; Tsai,Fuu-Jen; Bau,Da-Tian; Chang,Ling-Chu; Hsieh,Min-Tsang; Lu,Chi-Cheng; Kuo,Sheng-Chu; Yang,Jai-Sing

doi:10.3892/or.2024.8750

July-2024 Volume 52 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2024 Volume 52 Issue 1

Full Size Image

Correction Open Access

[Corrigendum] Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells

Authors:
- Yu-Jen Chiu
- Fuu-Jen Tsai
- Da-Tian Bau
- Ling-Chu Chang
- Min-Tsang Hsieh
- Chi-Cheng Lu
- Sheng-Chu Kuo
- Jai-Sing Yang
View Affiliations / Copyright

Affiliations: Division of Plastic and Reconstructive Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan, R.O.C., Human Genetic Center, China Medical University, Taichung 40402, Taiwan, R.O.C., Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan, R.O.C., Chinese Medicinal Research and Development Center, China Medical University Hospital, Taichung 40402, Taiwan, R.O.C., Department of Sport Performance, National Taiwan University of Sport, Taichung 40402, Taiwan, R.O.C.

Copyright: © Chiu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 91
|
Published online on: June 3, 2024

https://doi.org/10.3892/or.2024.8750
Expand metrics +

Article

Oncol Rep 46: [Related article:] 133, 2021; DOI: 10.3892/or.2021.8084

Subsequently to the publication of the article, an interested reader drew to the authors’ attention that, in Fig. 2A on p. 5, the ‘Control (24 h)’ and ‘MTH-3 (1 μM; 24 h)’ data panels contained partially overlapping data, such that they appeared to have been derived from the same original source. The authors have examined their original data, and realized that this error arose inadvertently as a consequence of having compiled this figure incorrectly.

Figure 2.

MTH-3 suppressed invasion and migration in human breast adenocarcinoma MDA-MB-231 cells. (A) The invasion ability of MDA-MB-231 cells was evaluated using a Matrigel®-coated invasion chamber. Following treatment with various concentrations of MTH-3 for 24 h, the invading MDA-MB-231 cells in the lower chamber were stained and subsequently counted under a light microscope (magnification, ×200). (B) Tumor cell invasion was semi-quantified. (C) The ability of migration of MDA-MB-231 cells was evaluated by wound healing assay. Following treatment with the various concentrations of MTH-3 for 24 h in serum-free Leibovitz's L-15 medium, MDA-MB-231 cells were photographed. (D) The migrated tumor cells were quantified. Data are presented as the mean ± standard deviation of three experiments. *P<0.05. MTH-3, (1E,3Z,6E)-3-hydroxy-5-oxohepta-1,3,6-triene-1,7-diyl)bis(2-methoxy-4,1-phenylene)bis(3-hydroxy-2-hydroxymethyl)-2-methyl propanoate.

The revised version of Fig. 2, featuring the data from one of the repeated experiments in Fig. 2A, is shown below. The revised data shown for this figure do not affect the overall conclusions reported in the paper. The authors apologize to the Editor of Oncology Reports and to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells

This article is mentioned in:

Article

Figure 2.

Related Articles